Of oral etoricoxib, and intravenous ketoprofen cerebrospinal fluid concentrations and their effect on prostaglandin E2 concentrations in adult hip joint replacement surgery [Suun kautta annosteltavan etorikoksibin ja laskimoon annosteltavan ketoprofeenin aivo selkäydin nestepitoisuudet ja niiden vaikutus prostaglandiini-E2-pitoisuuksiin aikuisten lonkan tekonivelleikkauksen jalkeen]

Trial Profile

Of oral etoricoxib, and intravenous ketoprofen cerebrospinal fluid concentrations and their effect on prostaglandin E2 concentrations in adult hip joint replacement surgery [Suun kautta annosteltavan etorikoksibin ja laskimoon annosteltavan ketoprofeenin aivo selkäydin nestepitoisuudet ja niiden vaikutus prostaglandiini-E2-pitoisuuksiin aikuisten lonkan tekonivelleikkauksen jalkeen]

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2014

At a glance

  • Drugs Etoricoxib (Primary) ; Ketoprofen
  • Indications Pain
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 25 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top